Michael Harris

Michael Harris has a diverse work experience spanning several industries. Michael currently serves as a Non Executive Director at Renovos Biologics Limited since July 2023. Prior to this, they held the position of CEO at Biocomposites starting from March 2019. From May 2017 to December 2018, they worked as the COO at Ethypharm. Before that, they were the CEO at Martindale Pharma from July 2014 to May 2017. From September 2013 to July 2014, they served as the General Manager at GE Healthcare. Michael also worked at Sigma-Aldrich, where they held various roles, including Vice President Pharma Business Segment from January 2013 to August 2013, Managing Director EMEA from October 2009 to December 2012, Managing Director UK from July 2007 to October 2009, and Vice President SAFC Pharma Europe from July 2004 to October 2009. Michael started their career as a Business Development Manager at Ultrafine from 2001 to 2004. From 1999 to 2001, they served as a Business Development Manager at Chirotech Technology Ltd, and from 1994 to 1999, they worked as a Scientist at the same company.

Michael Harris earned a Bachelor of Science degree in Chemistry from the University of Warwick, where they studied from 1988 to 1991. Michael then went on to pursue a PhD in Chemistry at the University of Southampton from 1991 to 1994.